http://www.unboundmedicine.com/medline/ebm/research/aspirinUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19893641/full_citation/Late_thrombosis_of_sirolimus_eluting_stent:_a_multifactorial_problem_Kranjec I, Cerne A 
Late thrombosis of sirolimus-eluting stent: a multifactorial problem. [Journal Article]
Case Report Med 2009.:816715.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19893289/full_citation/Low_dose_aspirin_for_management_of_cerebrovascular_diseases_Kitazono T, Iida M 
Low-dose aspirin for management of cerebrovascular diseases. [Journal Article]
Nippon Shokakibyo Gakkai Zasshi 2009 Nov; 106(11):1596-602.
Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19893288/full_citation/Diabetes_and_a_low_dose_of_aspirin_Araki S, Kashiwagi A 
Diabetes and a low dose of aspirin. [Journal Article]
Nippon Shokakibyo Gakkai Zasshi 2009 Nov; 106(11):1589-95.
Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19893286/full_citation/Gastro_intestinal_injury_caused_by_NSAIDs_and_low_dose_aspirin_Iwakiri R 
Gastro-intestinal injury caused by NSAIDs and low-dose aspirin. [Journal Article]
Nippon Shokakibyo Gakkai Zasshi 2009 Nov; 106(11):1575-81.
Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19892664/full_citation/Chemopreventive_efficacy_of_naproxen_and_nitric_oxide_naproxen_in_rodent_models_of_colon_urinary_bladder_and_mammary_cancers_Steele VE, Rao CV, Zhang Y, et al. 
Chemopreventive efficacy of naproxen and nitric oxide-naproxen in rodent models of colon, urinary bladder, and mammary cancers. [Journal Article, Research Support, N.I.H., Extramural]
Cancer Prev Res (Phila Pa) 2009 Nov; 2(11):951-6.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19892299/full_citation/New_antiplatelet_agents:_why_they_are_needed_Franchini M, Mannucci PM 
New antiplatelet agents: why they are needed. [Journal Article]
Eur J Intern Med 2009 Dec; 20(8):733-8.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19892050/full_citation/Effectiveness_of_two_year_clopidogrel_+_aspirin_in_abolishing_the_risk_of_very_late_thrombosis_after_drug_eluting_stent_implantation__from_the_TYCOON_[two_year_ClOpidOgrel_need]_study__Tanzilli G, Greco C, Pelliccia F, et al. 
Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study). [Journal Article]
Am J Cardiol 2009 Nov 15; 104(10):1357-61.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19890822/full_citation/Prevalence_of_hypersensitivity_to_non_steroidal_anti_inflammatory_drugs__NSAIDs__in_the_population_of_adult_asthmatics_in_Poland_based_on_an_epidemiological_questionnaire_Kasper L, Sładek K, Bochenek G, et al. 
Prevalence of hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs) in the population of adult asthmatics in Poland based on an epidemiological questionnaire. [Journal Article]
Pneumonol Alergol Pol 2009; 77(5):431-9.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19890703/full_citation/Oral_Antiplatelet_Therapy_for_Acute_and_Chronic_Management_of_NSTE_ACS:_Residual_Ischemic_Risk_and_Opportunities_for_Improvement_Cohen M 
Oral Antiplatelet Therapy for Acute and Chronic Management of NSTE ACS: Residual Ischemic Risk and Opportunities for Improvement. [JOURNAL ARTICLE]
Cardiovasc Drugs Ther 2009 Nov 5.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19888916/full_citation/Clopidogrel_application:_beyond_coronary_artery_disease_Zeng C 
Clopidogrel application: beyond coronary artery disease. [JOURNAL ARTICLE]
Clin Sci (Lond) 2009 Nov 4.
Abstract | Full Citation | Find Related Articles